The Right Intervention for the Wrong Person Is Still the Wrong Intervention

An intervention can have credible research behind it and still be an unsuitable choice for the person sitting in front of you.
That can be difficult to appreciate when health information is presented as lists of the “best” foods, supplements, exercises or treatments.
Best for whom? For which goal? Under what circumstances?
Those questions determine whether promising information becomes useful care.
Evidence tells us what happened in a particular setting
A clinical study examines an intervention in a defined group of people, under particular conditions, over a specified period.
Applying its findings requires us to consider how closely those circumstances match the person we are helping.
Were the participants deficient in a nutrient? Did they have a confirmed diagnosis? Were they taking other treatments? Was the outcome a symptom improvement, a laboratory change or a reduction in major health events?
These details shape what we can reasonably expect.
A benefit demonstrated in one setting should not automatically become a recommendation for everyone.
Suitability depends on the goal
An intervention can be useful while doing little for the outcome someone wants.
A strategy that supports relaxation may be worthwhile, but that does not establish that it treats the cause of persistent fatigue.
A product that changes an antioxidant marker has not necessarily been shown to improve symptoms or prevent disease.
A treatment that helps reduce body weight still needs to be considered alongside nutrition, strength, function and the person’s broader health.
Before choosing an intervention, we need to define what success would look like.
Timing and circumstances matter
The same person’s needs can change.
Someone working towards fat loss may later need a different plan to rebuild strength or maintain weight. Someone recovering from illness may need nutritional support before pursuing an ambitious exercise programme.
Medication changes, new symptoms and changes in kidney or liver function can also alter what is appropriate.
Personalisation is therefore an ongoing process. A recommendation should be reviewed as circumstances change.
Traditional use deserves careful interpretation too
International traditions can broaden the options we consider. They can offer culturally familiar foods, movement practices and botanical approaches that people find meaningful and practical.
But traditional use still requires context.
What was the preparation? What was it used for? Does the available research support that use? Could it interact with current treatment?
The same questions apply to newer interventions. Novelty alone does not establish value, and limited research should be described clearly rather than concealed behind confident language.
Choosing well includes knowing when to stop
A sensible plan needs a way to judge whether it is helping.
That means agreeing on the intended outcome, a reasonable review period and any safety monitoring. It also means being willing to reconsider an intervention that is ineffective, poorly tolerated or too difficult to sustain.
Continuing indefinitely because something “should work” is not the same as observing that it does.
Sometimes a simpler plan offers greater value because the person can follow it consistently and its effects are easier to assess.
The principle guiding my app
The app I’m developing is built around this question:
Does this intervention make sense for this person, for this goal, at this time?
That requires bringing potential benefits together with evidence strength, practical considerations, interactions and monitoring.
The purpose is to support decisions that can be explained, reviewed and adjusted—not to turn every promising intervention into a recommendation.
A treatment’s value depends on more than what it can do. It also depends on whether its benefits, risks and demands fit the person who may use it.
Dr D Michael Elliott MSc, D.C., CFMP



